NCT00133406

Brief Summary

The primary objectives of this study are to determine the effect of 1 year supplementation of Vitamin A, Zinc, and Vitamin A plus Zinc compared to placebo on the Height for Age Z Score (HAZ) and the number of episodes of diarrhea and number of days of diarrhea at one year in children living in a Brazilian slum. Study participants will include 280 children ages 2 months to 8 years old, with a Height for Age Z score (HAZ) less than median for the Parque Universitario community, living in Brazilian favela. There is also a sub study to determine if ten days of glutamine delivered as an oral bolus improves the health of the digestive system.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
321

participants targeted

Target at P50-P75 for phase_3

Timeline
Completed

Started Jun 2006

Longer than P75 for phase_3

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 19, 2005

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 23, 2005

Completed
9 months until next milestone

Study Start

First participant enrolled

June 1, 2006

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
Last Updated

March 8, 2011

Status Verified

March 1, 2011

Enrollment Period

5.5 years

First QC Date

August 19, 2005

Last Update Submit

March 4, 2011

Conditions

Keywords

Brazil, Child Nutrition Disorders, Deficiency Diseases

Outcome Measures

Primary Outcomes (1)

  • L:M ratio at 1.5 months

    1.5 months

Secondary Outcomes (3)

  • L:M ratio at 4 & 12 months

    4 and 12 months

  • HAZ

    1.5, 4, 8, 12, 24, and 36 months

  • Diarrhea burden

    4, 8, 12, 24, and 36 months

Study Arms (6)

a

EXPERIMENTAL

oral glutamine with juice for 10 days

Drug: Glutamine

b

EXPERIMENTAL

PO vit A q 4 mo for 1 year plus zinc placebo

Drug: Vitamin ADrug: zinc

c

ACTIVE COMPARATOR

Zinc 40 mg twice weekly Plus Vitamin A Placebo for one year

Drug: Vitamin ADrug: zinc

d

PLACEBO COMPARATOR

oral glycine with juice daily for 10 days

Drug: glycine

e

PLACEBO COMPARATOR

Vitamin A Placebo plus Zinc Placebo for one year

Drug: Vitamin ADrug: zinc

f

EXPERIMENTAL

Vitamin A q 4 months and PO Zinc for 1 year

Drug: Vitamin ADrug: zinc

Interventions

0.8gm/kg, ie up to a total daily dose of 16.2gm/day,with juice daily for 10 days

a

100,000 IU for children under 12 months of age (or placebo) and PO 200,000 IU for children at least 12 months of age (or placebo), both q months for 1 year at 0, 4 and 8 months.

bcef

0.4gm/kg; ie up to 8.3gm/d, with juice daily for 10 days

d
zincDRUG

40 mg twice weekly for 12 months

bcef

Eligibility Criteria

Age2 Months - 8 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children ages 2 months to 8 years with height for age Z-score (HAZ) less than the median for the Parque Universitario community. Be a resident in Brazilian flavela. Child's parent or guardian must sign informed consent.

You may not qualify if:

  • Children exclusively breast-fed. Children who participated in the "hospital study" or any other study with in the past two years. Children with fever \> 102 F at time of screening. Children with systemic disease at the time of screening including but not limited to: shock, meningitis, sepsis, pneumonia, tuberculosis, varicella. Children on antibiotics during screening. Children with siblings from the same household enrolled in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Federal University of CearĂ¡

Fortaleza, 60436160, Brazil

RECRUITING

Related Publications (4)

  • Lima AA, Anstead GM, Zhang Q, Figueiredo IL, Soares AM, Mota RM, Lima NL, Guerrant RL, Oria RB. Effects of glutamine alone or in combination with zinc and vitamin A on growth, intestinal barrier function, stress and satiety-related hormones in Brazilian shantytown children. Clinics (Sao Paulo). 2014;69(4):225-33. doi: 10.6061/clinics/2014(04)02.

  • Lima AA, Kvalsund MP, Souza PP, Figueiredo IL, Soares AM, Mota RM, Lima NL, Pinkerton RC, Patrick PP, Guerrant RL, Oria RB. Zinc, vitamin A, and glutamine supplementation in Brazilian shantytown children at risk for diarrhea results in sex-specific improvements in verbal learning. Clinics (Sao Paulo). 2013;68(3):351-8. doi: 10.6061/clinics/2013(03)oa11.

  • Mitter SS, Oria RB, Kvalsund MP, Pamplona P, Joventino ES, Mota RM, Goncalves DC, Patrick PD, Guerrant RL, Lima AA. Apolipoprotein E4 influences growth and cognitive responses to micronutrient supplementation in shantytown children from northeast Brazil. Clinics (Sao Paulo). 2012;67(1):11-8. doi: 10.6061/clinics/2012(01)03.

  • Lima AA, Soares AM, Lima NL, Mota RM, Maciel BL, Kvalsund MP, Barrett LJ, Fitzgerald RP, Blaner WS, Guerrant RL. Effects of vitamin A supplementation on intestinal barrier function, growth, total parasitic, and specific Giardia spp infections in Brazilian children: a prospective randomized, double-blind, placebo-controlled trial. J Pediatr Gastroenterol Nutr. 2010 Mar;50(3):309-15. doi: 10.1097/MPG.0b013e3181a96489.

MeSH Terms

Conditions

Child Nutrition DisordersDeficiency Diseases

Interventions

GlutamineVitamin AGlycineZinc

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic DiseasesMalnutrition

Intervention Hierarchy (Ancestors)

Amino Acids, BasicAmino AcidsAmino Acids, Peptides, and ProteinsAmino Acids, DiaminoAmino Acids, NeutralRetinoidsCarotenoidsPolyenesAlkenesHydrocarbons, AcyclicHydrocarbonsOrganic ChemicalsCyclohexenesCyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicTerpenesDiterpenesPigments, BiologicalBiological FactorsMetals, HeavyElementsInorganic ChemicalsTransition ElementsMetals

Study Officials

  • Richard L Guerrant, MD

    University of Virginia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Richard Guerrant

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 19, 2005

First Posted

August 23, 2005

Study Start

June 1, 2006

Primary Completion

December 1, 2011

Study Completion

December 1, 2011

Last Updated

March 8, 2011

Record last verified: 2011-03

Locations